← All organizations

TissueGene, Inc.

For profit

Also known as: Kolon Life Science | Kolon TissueGene, Inc. | TissueGene, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2025

Timeline

1990s

Jun 1, 1999
TissueGene, Inc.— Founded

Drugs by trial phase (4 distinct, 13 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

kls-2031

Indications

Studied for

Recent trials (14)

NCT06144970Lead sponsorPhase 1Nov 1, 2025
NCT05276011Study chairPhase 2Oct 31, 2023
NCT05276011Lead sponsorPhase 2Oct 31, 2023
NCT04238793Lead sponsorPhase 1/Phase 2Feb 3, 2020
NCT03291470Lead sponsorPhase 3Sep 16, 2018
NCT03203330Lead sponsorPhase 3Sep 16, 2018
NCT03383471Lead sponsorPhase 3Feb 12, 2018
NCT02072070Lead sponsorPhase 3Nov 1, 2013
NCT01825811Lead sponsorPhase 2Oct 1, 2012
NCT01671072Lead sponsorPhase 2Jul 1, 2011
NCT01221441Lead sponsorPhase 2May 1, 2011
NCT02341378Lead sponsorPhase 2Aug 1, 2009
NCT02341391Lead sponsorPhase 1Feb 1, 2007
NCT00599248Lead sponsorPhase 1Jan 1, 2007

Details

Founded: Rockville, MD, US Jun 1, 1999
Last known activity: Nov 1, 2025